
Century Therapeutics rose 185.2% from $0.48 to $1.37, ahead of the S&P 500's +10.0%. Its worst day was Nov 17 (−16.5%), and its low came Nov 17 at $0.48.
Nov 17, 2025 – Nov 17, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Century Therapeutics shares rose 17.9%, while the S&P 500 rose 0.9%.
+17.9% · S&P 500 +0.9%
Century Therapeutics shares rose 44.4%, while the S&P 500 fell 0.3%.
+44.4%, the year's best day · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
EPS of $-0.25 beat the $-0.29 estimate on $0.00 revenue (est. $-62,500.00).
−8.4% · S&P 500 −1.5%
EPS of $-0.11 beat the $-0.17 estimate on $0.00 revenue.
−0.4% · S&P 500 +0.6%
EPS of $-0.17 missed the $-0.12 estimate on $0.00 revenue.
−4.9% · S&P 500 +0.3%
EPS of $-0.11 beat the $-0.11 estimate on $0.00 revenue.
−6.3% · S&P 500 −0.4%
Where it ended: a close of $1.37 on Nov 17, 2026. Up next: Q4 2026 earnings on Mar 11, 2027 (EPS est. $-0.12).
Nothing in the past 12 months.
All IPSC dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for IPSC and SPY from Benzinga historical bars. Not investment advice.